FindTrial
Sign In

A study to understand the late side-effects and difficulties faced in retinoblastoma survivors.

Late effect burden and Patient reported outcomes in long term survivors of Retinoblastoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/109907
Enrollment
300
Registered
2026-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C69- Malignant neoplasm of eye and adnexa

Interventions

Intervention1: NA: NA Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil Control Intervention1: NA: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Retinoblastoma survivors,More than 2 years from completion of treatment,For assessment of patient reported outcomes,age greater than 5 yrs of age,Able to answer self administered or interviewer administered validated questionnaires, Understanding English/Hindi/Marathi

Exclusion criteria

Exclusion criteria: Lack of consent,For assessment of patient reported outcomes,Language Barrier

Design outcomes

Primary

MeasureTime frame
To investigate the profile and cumulative burden of late effects in childhood retinoblastoma survivorsTimepoint: On yearly follow-up—

Secondary

MeasureTime frame
To evaluate the health-related quality of life (HRQoL) using European Organisation forResearch and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ C-30) in survivors aged 18 years or above and Pediatric Quality of Life Inventory (PedsQL) in survivors aged less than 18 years. To evaluate the vision targeted health-related quality of life (HRQoL) using National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25).To evaluate the impact of the disease as well as the therapeutic intervention on the visual acuity and health-related quality of life (HRQoL).Timepoint: On yearly follow-up—

Countries

India

Contacts

Public ContactDr VENKATA GOLLAMUDI

Tata Memorial Hospital

vencatram@gmail.com8450976539

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026